Deferoxamine, Resveratrol, and zinc acetate target the amyloid precursor protein (APP) gene, which is upregulated in aging and was also found to be upregulated in both MDD with and without comorbid anxiety disorder through our analysis. The gene discussed is APP; the disease is major depressive disorder.